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Background: Patient decision aids (PtDA) are developed to facilitate informed, value-based decisions about health.
Research suggests that even when informed with necessary evidence and information, cognitive errors can prevent
patients from choosing the option that is most congruent with their own values. We sought to utilize principles of
behavioural economics to develop a computer application that presents information from conventional decision
aids in a way that reduces these errors, subsequently promoting higher quality decisions.
Method: The Dynamic Computer Interactive Decision Application (DCIDA) was developed to target four common
errors that can impede quality decision making with PtDAs: unstable values, order effects, overweighting of rare
events, and information overload. Healthy volunteers were recruited to an interview to use three PtDAs converted
to the DCIDA on a computer equipped with an eye tracker. Participants were first used a conventional PtDA, and
then subsequently used the DCIDA version. User testing was assessed based on whether respondents found the
software both usable: evaluated using a) eye-tracking, b) the system usability scale, and c) user verbal responses
from a ‘think aloud’ protocol; and useful: evaluated using a) eye-tracking, b) whether preferences for options were
changed, and c) and the decisional conflict scale.
Results: Of the 20 participants recruited to the study, 11 were male (55%), the mean age was 35, 18 had at least a
high school education (90%), and 8 (40%) had a college or university degree. Eye-tracking results, alongside a mean
system usability scale score of 73 (range 68–85), indicated a reasonable degree of usability for the DCIDA. The think
aloud study suggested areas for further improvement. The DCIDA also appeared to be useful to participants
wherein subjects focused more on the features of the decision that were most important to them (21% increase in
time spent focusing on the most important feature). Seven subjects (25%) changed their preferred option when
using DCIDA.
Conclusion: Preliminary results suggest that DCIDA has potential to improve the quality of patient decision-making.
Next steps include larger studies to test individual components of DCIDA and feasibility testing with patients
making real decisions.
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In recent years, numerous patient decision aids (PtDA)
have been developed to facilitate informed, value based
decisions about treatment options [1]. They have been de-
veloped in response to many beneficial treatments or
screening strategies which also have negative aspects such
as side-effects or high costs. What is best for one patient
may be different to another depending on how each values
the attributes of each option [2]. Health professionals are
often poor proxies of patients’ values [3,4], and often fail
appropriately ‘diagnose’ patient preferences [5]. Patients
can also have unrealistic expectations of treatment bene-
fits and harms [6].
PtDAs provide facts about the condition, options, and
attributes such as outcomes and probabilities for each op-
tion; a value clarification task that helps patients evaluate
which attributes matter most to them; and a guide in the
steps of deliberation and communication required for the
informed patient to reach their goal – concordance be-
tween what matters most to them and their chosen option
[7]. An updated Cochrane systematic review found that,
among 115 studies involving 34,444 participants, PtDA in-
crease patients’ knowledge about treatment options, and
reduce their decisional conflict related to feeling unin-
formed and unclear about their personal values [1].
There have been tremendous advances in the way
PtDAs are developed, from the way risks are presented
[8], to the use of animated stories to better communicate
information [9]. However, there has been comparatively
little research on reducing decision errors in people
using PtDAs [10]. While in theory, PtDAs should help
patients identify the best treatment option for them, re-
search shows that various cognitive biases may result in
errors that prevent this in some situations [11-14]. For
example, individuals are known to make different choices
when their options are framed as gains or losses, prefer-
ring a surgical procedure with a 90% survival rate to one
with a 10% mortality rate [15]. Studies have shown that in-
dividual treatment choices are unduly influenced by
whether individuals learn first about potential harms or
potential benefits [10], and individuals are intimidated and
overwhelmed by options that include numerous rare side-
effects leading to irrational decisions [16].
The objective of this study was to develop and user test
a computer application that enhances conventional PtDAs
to improve the quality of decisions by helping patients
overcome common decision errors.
Development of DCIDA
Theoretical motivation
Normative decision theory suggests that for patients to
approach treatment or screening decisions rationally
they need to weigh benefits and harms using deliberative
“compensatory strategies” to make trade-offs [17]. Thatis, a patient can “compensate” for the negative feature of
one option by considering a positive feature. A patient
looking at cancer screening options may not want to
have annual testing, but would not mind if such frequent
testing were non-invasive. While this approach helps
people identify the treatment option that matches their
informed values, descriptive decision theory has identi-
fied numerous errors in peoples’ decisions caused by
cognitive biases and simplifying heuristics [12-15]. An
understanding that people have two systems for cogni-
tive functioning has provided a framework for under-
standing these errors and providing effective strategies
for improving decision making [18]. System 1 refers to
people’s intuitive system, which is typically fast, auto-
matic, effortless, implicit, and emotional. While often
useful for simple decisions, they can lead to decision er-
rors for more difficult decisions, such as ones requiring
compensatory strategies. System 2 refers to reasoning
that is slower, conscious, effortful, explicit, and logical.
Recent research suggests that when faced with decisions
and information that is unfamiliar, complex, or over-
whelming – all common traits targeted by most PtDAs –
people can switch to use System 1 functioning, which can
lead to decision errors [12,13].
By reviewing PtDAs contained in the Ottawa repository
[19], the project team identified few examples where PtDAs
helped patients making trade-offs, and beyond simple value
clarification exercises gave patients little help in choosing
what was best for them. The team identified four issues
common to nearly all PtDAs that were believed could im-
pede the quality decision-making, and for which interven-
tions were feasible: unstable preferences, order effects,
overweighting of rare events, and information overload.
i) Unstable values: Unlike most goods and services,
where markets help form stable values and
consumers understand the relative value of
attributes through a process of trial and error and
notion of sacrifice, evidence indicates that patients
often have unstable values when it comes to health
care [20,21]. This follows from the fact that the
potential benefits and harms of treatment may be
unfamiliar to patients and impossible to evaluate
without a great deal of information and reflection.
The consequence is that people’s decisions may be
inconsistent with their true underlying values.
ii) Order effects: For a rational decision maker, the way
information is presented should not have an
influence on the choice that is made. However, there
is evidence that people tend to, for example,
remember information presented to them first
(primacy effect) or last (recency effect) [22-24]. The
decision error in PtDAs caused by this heuristic is
demonstrated in a study of women at high risk of
Bansback et al. BMC Medical Informatics and Decision Making 2014, 14:62 Page 3 of 13
http://www.biomedcentral.com/1472-6947/14/62breast cancer who were considering tamoxifen, which
found that patients who learned first about the risks of
the drug thought more favourably of tamoxifen than
patients who learned first about the benefits [10].
Nevertheless, harms and benefits must be presented
in some order in a PtDA, and therefore, the designer
of the PtDA may inadvertently influence the patient to
choose a given option.
iii)Overweighting of rare events: Most treatments have
multiple complications. PtDAs are expected to
inform patients about any treatment complication
that is reasonably likely to occur. Although there are
no absolute criteria regarding which complications
must be included for meeting informed consent,
most PtDAs show information on any moderately
severe complication that occurs at least 1% of the
time, and serious complications that occur even less
often than that. Prospect theory describes how people
systematically overweigh small probabilities in terms
of their impact on decisions. The consequence of this
phenomenon is that patients using PtDAs can be
scared away from treatments with multiple rare
side-effects that rationally would have appeared the
best treatment option for them [14,16].
iv) Information overload: When individuals receive
conflicting, incomplete, uncertain, or excessive
information, they experience ambiguity and can
make contradictory decisions [25]. The role of
information overload causing ambiguity in investment
decision-making has been well documented. When
the complexity of decision-making increases, people
tend to expend less effort to actually make their
decision, seek others to make decisions for them,
or select default options if available [26].
A number of promising strategies have been uncov-
ered for overcoming specific decision errors. One ap-
proach is to encourage people to use System 2 thinking
instead of System 1 by making the information and de-
cision less overwhelming. This can be achieved by fo-
cussing attention on the most pertinent information,
and by using analytic processes which reduce the num-
ber of ‘internal calculations’ which require cognitive ef-
fort [27-30]. In the area of PtDAs, the predominant
approach has been to employ formal decision analysis
techniques which quantifies patients' values and inte-
grates them with probabilistic information [31-33].
While there are many perceived advantages to this pre-
scriptive approach, there are also criticisms. First, ‘opti-
mal’ options derived from decision analysis are reliant
on assumptions, theories and inaccuracies in inputs
which mean they may not actually prescribe the best
course of action for each patient [34]. Second, the
current approaches to decision analysis are typically‘overt’ to be best course of action, and consequently have
been argued to be an extension of paternalism, comprom-
ising patient autonomy [35].
An alternative strategy is to leverage System 1 thinking
by changing the decision environment to maximize the
odds that people will make high quality decisions given
known biases [26]. For example, it is known that most
people have a bias towards inaction, in which providing a
default option has been found to be a powerful decision
enhancer [36]. These strategies have increasingly been re-
ferred to as ‘nudges’, reflecting the unavoidable paternalis-
tic role of the designer of the tool (in this case, PtDAs) in
influencing users’ choices [37]. Nudges have been defined
as “…any aspect of the choice architecture that alters peo-
ple’s behavior in a predictable way without forbidding any
options or significantly changing their economic incen-
tives…” [37], and so seek to preserve patient autonomy
and freedom of choice.
We sought to employ decision analysis more covertly
[38] to improve decision-making by testing various ‘nudges’
which help people focus on the information and options
that reflect their values, and simplify their trade-offs.
Features
We developed a dynamic computer interactive decision
application (DCIDA - pronounced ‘decider’) to employ
some of the strategies described above. The overarching
aim of the DCIDA is to present information and the de-
cision to each person in an individualized way in order
to maximize their ability to make choices that reflect
their own informed, stable values. Acknowledging that it
is rare that any decision support system will induce opti-
mal decisions, the goal is to improve the quality of deci-
sions, from what would be made with conventional
PtDAs. Multi-criteria decision analysis (MCDA) using a
weighted additive model motivates the application. For
treatment decisions, this assumes the preferred option is
based on the sum of the importance or weight (on a 0–
100 scale) of each attribute, say benefit or harm, multi-
plied by each option’s score (on a 0–100 scale) for that
attribute. The treatment with the highest weighted score
or expected value indicates the patient’s optimal option.
The application contains the same content and informa-
tion as a PtDA, explaining the condition, providing infor-
mation about options and their characteristics (benefits,
side-effects, costs etc.) using probabilities and pictographs
to describe baseline and incremental absolute risks where
appropriate, a value clarification exercise, and a summary
of information to help the patient deliberate on the deci-
sion along with an opportunity to select the preferred op-
tion. However, the way this content and information is
structured and organized differs, and where possible indi-
vidualized to make it simpler for each person to choose
what is best for them. Figure 1 compares the pathway a
Figure 1 Different pathways for obtaining information and indicating preferences for DCIDA vs conventional PtDA.
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version of a PtDA. For example, the first unique feature of
the DCIDA is that in step 1 the value clarification task,
which is usually near the end of a conventional PtDA, is
moved to the beginning. The objective of the task was to
a) provide an opportunity for individuals to reflect on the
relative value of attributes and subsequently derive more
stable values (see “i) Unstable values” above) and b) to
generate the weights for each attribute for use later in the
tool. After preliminary testing, we decided to use aninteractive form of constant sum exercise (also known as a
“budget pie”) which requires users to allocate a certain
number of points (often 100) to each attribute in accord-
ance with the relative importance of each. Constant sum
exercises have a long history of use and incorporate a
number of properties desirable for encouraging compen-
satory decisions [39], but have been criticized for requiring
a higher levels of numeracy [40]. We developed a simpler
version that requires users to move multiple sliders, all
linked to an interactive pie chart (Figure 2). For individuals
Figure 2 Example of constrained interactive pie chart.
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for communicating the “gist” of health knowledge and
treatment choices [41]. As participants navigated through
the following steps of the DCIDA version, they could re-
turn at any time to the budget pie exercise to change the
weights allocated to different attributes of the decision.
After the values clarification task, Step 2 presented par-
ticipants with detailed information (e.g. the actual risk) for
each attribute. Where possible, the information was ex-
plained in a simple format, including pictographs where
necessary to communicate risks. Importantly, this infor-
mation was ordered in accordance with the rank of the in-
dividual’s weights – obtained from the value clarification
exercise. For each attribute, the patient was asked to rate
how important the attribute (outcome such as benefit or
harm) for each option. This was used to create the score
for each attribute. In our preliminary testing we used a
simple 5-point scale to derive numerical scores.
In step 3, the summary information for all consequences
was displayed. In contrast to a conventional PtDA: 1) the
consequences were ordered in accordance with the rank
of the individual’s weights – obtained from the value clari-
fication exercise. This aimed to exploit order effects by
nudging individuals to focus on the information that
would most significantly influence their decision (see “ii)
Order effects” above); 2) rows were further sized in propor-
tion to the weights of each consequence, with the most
important consequences being presented in wide rows
and less important consequences in narrow rows. This
served to take attention away from rare events for the ma-
jority of people who rated these attributes to have lowimportance in the value clarification exercise (see “iii)
Overweighting of rare events” above); 3) for each conse-
quence, the colour for each option was based on the score,
with a lighter shade of grey indicating a more preferred
option. Colouring aimed to simplify the information pre-
sented (akin to traffic light labelling for the nutritional of
food [42]), enabling individuals to process multiple pieces
of information and distinguish between harms and bene-
fits (see “iv) Information overload” above); 4) the sum of
the weights and scores were used to determine which op-
tion would be preferred using MCDA (Figure 3). This in-
dicated the ‘optimal’ choice for a given individual and
became the default option for the participant, helping
overcome information overload. On the summary page,
users were able to select an option other than the default
optimal choice; however the presence of a selected default
option has proven to help overcome ambiguity [36].
Development
Three PtDAs available to the developers were transformed
into DCIDA versions. The goal was to ensure the DCIDA
was usable for a broad range of PtDAs, each of which has a
different set of individual characteristics. The first PtDA
used information on newly developed over the counter
medication choices for the treatment of knee osteoarthritis,
where it is suspected patients underestimate the risks asso-
ciated with high doses. The options were no treatment,
acetaminophen (lower benefit, but fewer side-effects), and
non-steroidal anti-inflammatory drugs (NSAIDs) (greater
benefit, but greater side-effects). The second PtDA focussed
on treatment options for patients with Obstructive Sleep
Figure 3 Example of conventional MCDA weights and scores, and total scores and DCIDA.
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positive airway pressure (CPAP), which is effective but in-
convenient to use. Less invasive alternatives such as oral ap-
pliances or no treatment are also options. The third PtDA
considers chemotherapy options for patients with late stage
non-small cell lung cancer (NSCLC). Treatments with
higher efficacy are also associated with more frequent and
severe side-effects. All three PtDAs were conceived using
the Ottawa Framework [43] and were reviewed to Inter-
national Patient Decision Aid Standards (IPDAS) guidelines
[7]. DCIDA versions of each PtDA were made using exactly
the same information. An example of the DCIDA version
of the PtDAs is available at: http://dcida.cheos.ubc.ca/osa1.
Methods
Overview
We focussed our user testing on both usability (whether
the user can do what they want to do to without hin-
drance, hesitation, or questions) and usefulness (does it
help the user make a better decision) [44]. Two common
approaches to user testing were used – eye-tracking and a
think aloud protocol – and these were supplemented with
various validated questionnaires. Ethics was granted from
University of British Columbia Ethics Board.
Participants and procedures
A sample of healthy, English-speaking volunteers was
recruited through online advertisements and posters.Participants were seated at a computer equipped with
an eye-tracker and the interviewer explained the pur-
pose of the study. After gaining consent, the participant
went through the calibration procedure to initialize the
eye-tracking system. The participant was then asked to
choose which clinical scenario they wanted to imagine
they were facing: Knee Osteoarthritis, OSA, or NSCLC,
and proceed to complete an online version of a conven-
tional PtDA followed by the DCIDA version created for
their chosen scenario.
Figure 1 shows the flow for the conventional PtDA. After
selecting their preferred option, they were asked to indicate
their uncertainty in their decision by completing the Deci-
sional Conflict Scale (DCS). They then went through the
DCIDA version (right side of Figure 1) and were again
asked to choose their preferred option, and their uncer-
tainty as measured by the DCS. Finally, they were asked to
complete the System Usability Scale (SUS) focussing on the
DCIDA. After completing the tool, an interview was used
to discover users’ impressions about the tool and their ex-
periences. Upon completion of the tasks, the user was com-
pensated with a $25 dollar gift certificate.
Eye-tracking
Eye tracking is a promising method for usability testing
since it can evaluate individuals’ information processing
while they deliberate on decisions [45]. It makes it possible
to determine what type of information individuals look at
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tracker method is widely used in marketing research as
well as research on cognitive processing and decision-
making processes [46].
When individuals look at information while reading or
searching, they continually make rapid eye movements
called saccades. Between saccades, the eyes remain rela-
tively still for approximately 200–500 ms [47]. Individuals
do not obtain new information during a saccade because
the eyes are moving too quickly. Rather, higher levels of
information processing require deeper cognitive processes
that can only be processed while the eyes are fixated. Re-
search on information processing is therefore mainly con-
cerned with fixation durations [47]. Fixation durations are
assessed by an infrared camera system built into the eye
tracker. This camera measures the light reflex on the cor-
nea of individuals sitting in front of the computer screen.
In this study, the eye-tracking data was used for two pur-
poses. First, to assess user experience, we analyzed heatmaps
of each page of the tool to ensure respondents were consist-
ently looking and reading the important aspects of design
such as instructions. Heatmaps visually display the areas in
which fixations on each page occur. Second, to assess use-
fulness we compared fixations between the conventional
display versus the DCIDA display. To analyze the eye-
tracker data, we subdivided areas of the summary screen
into areas of interest based on each attribute. The time indi-
viduals spend looking at relevant information in relation to
the total time needed to look at the whole summary infor-
mation was used to indicate attributes participants were
spending time deliberating on [47]. It is expressed by the
relative fixation duration, that is, the percentage of the time
spent fixating on each attribute relative to the time spent
looking at the whole summary information [47]. A Tobii
T120 eye tracker embedded in a 17” display was used.
Decisional conflict scale (DCS)
After stating a preference for one treatment, participants
were asked to evaluate their uncertainty in their decision
based on a subscale of the DCS [48]. The DCS is a vali-
dated scale that assesses patients’ conflict and uncertainty
in their decision. While the full scale comprises 16 items di-
vided into 5 subscales – uncertainty, inadequate knowledge,
values clarity, lack of support, and ineffective choice – we
focussed simply on the uncertainty subscale, the compo-
nent the DCIDA attempts to increase confidence in the
decision. This subscale includes three items: how clear the
patient is about the best choice, how sure they feel about
that choice, and how easy the choice was to make. All
items are reported on a 5 point Likert scale from strongly
agree to strongly disagree. Lower scores are desirable as
they indicated less conflict. An effect size of 0.06 to 0.3
has been reported to discriminate between decision sup-
porting interventions [49].System Usability Scale (SUS)
After completing the tool, participants were asked to an-
swer an adapted version of the SUS. This validated scale
asks 10 questions about aspects of user friendliness, con-
tent integration, and support needed to answer the tool
providing a score between 0 and 100 [50]. The SUS is a
commonly used quantitative assessment of usability. It is
useful for rough comparison purposes, including assessing
the effects of changes from one prototype iteration to the
next, and for drawing preliminary conclusions about over-
all usability of a system. To our knowledge there is no
established SUS threshold for usability, however previous
studies have shown that a SUS score above 68 is above
average for all studies that have used the scale, while a
score above 74 would place the system in the top 30%
[51]. We chose to adopt these thresholds for our study.
Think aloud study
We used a verbal protocol analysis, a form of ‘think aloud’
technique, to further investigate respondents’ choices [52].
Think aloud data can be obtained in two ways: concurrent,
where respondents are asked to verbalize their thoughts as
they complete a task, and retrospective, where respondents
are asked to describe what they were thinking after the
task was completed. Following experience from previous
studies, we used a hybrid approach whereby respondents
were asked to think aloud as they completed the tool,
however if they did not think aloud for a period of 10 sec-
onds, the interviewer would ask them to reflect back on
their choices [53]. This approach interferes less with re-
spondents’ thought processes while still allowing an ex-
ploration of how respondents were making choices.
Respondents were asked not to explain or plan what they
were saying, but to act as if they were speaking to them-
selves. Following the survey, the interviewer asked respon-
dents debriefing questions. In general, respondents were
asked how they found the information and choices they
were presented with and how they would improve the
tool. The interviews were tape-recorded and later tran-
scribed. Responses were coded by each step in the tool
and whether they were related to user experience or us-
ability. Two independent reviewers then coded the valence
of each comment (e.g. positive, negative or neutral) and
differences resolved by discussion.
Results
Participants
In total, 20 participants were recruited via posters and
completed the study. Eleven participants were male (55%),
a 15 participants were white, and the mean age was 35
(range 19–59) (Table 1). All but two participants had at
least a high school education and 8 (40%) had a college or
university degree. None of the participants were suffering
from a serious illness and only three participants were
Table 1 Participant characteristics
Value
Age, mean (range) 35.2 (19-59)





At least high school 18 (90%)
At least college or university graduate 8 (40%)
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dents chose to complete the OSA version and four each
chose the NSCLC and Osteoarthritis versions.Table 2 Results of system usability scale, decisional
conflict, and eye trackingUser experience
Eye-tracking
In general, heat maps suggested participants were reading
all the relevant information on each page. For the first 4
participants, it was noted that there were few fixations on
the titles of the scales of the value clarification task
(whether each attribute was more or less important). The
titles were increased in size and bolded, and this led to in-
creased fixations in subsequent participants.Conventional DCIDA
System Usability Score, mean (range) - 74 (68–85)
Decisional conflict uncertainty
subscale (0 = good, 4 = bad),
I am clear about the best choice for me 2.9 2.3
I feel sure about what to choose 2.8 2.2
This decision is easy for me to make 3.4 3.1
Overall score 50.4 38.3SUS
The mean SUS score for DCIDA was 73 and ranged from
68 to 85. This suggests that all participants considered the
tool better than average interfaces and that the tool has
reasonable usability overall. The lowest scores related to a
perception that the tool was unnecessarily complex. There
was no difference between the different PtDA versions.Mean fixation duration (secs)
Most important attribute 4.7 5.6
2nd most important attribute 4.2 3.3
Least important attribute 3.1 1.1
Other attributes 14.1 8.5
Other areas of the screen 16.2 12.8
Total 42.3 31.3
Mean relative fixation
Most important attribute 18% 30%
2nd most important attribute 16% 18%
Least important attribute 12% 6%
Relative fixation – in 7 participants
changed preference
Most important attribute 17% 34%
2nd most important attribute 14% 19%
Least important attribute 10% 5%Think aloud analysis
In total, the think aloud analysis yielded 65 comments re-
lating to user-experience. Positive comments were gener-
ally around the interactive features of the tool and its ease
of moving from step to step. The subject of negative com-
ments included the amount of words required to read, the
wording of key instructions and a lack of intuitiveness in
how to interact with some features (such as the value
clarification exercise). Overall, 16 out of 20 (80%) stated
they had no major issues while using the tool. The 4 par-
ticipants that suggested the tool was difficult to use were
all in the oldest age quartile. Points of improvement in-
cluded: provision of examples to show how to interact
with key features (9 out of the 20 [45%]), clearer colours,
speed of the software, and wording of certain questions
(all less than 25% of participants).Usefulness
Eye-tracking
Regardless of the type of summary, we observed an order
effect whereby respondents spent more time observing the
attributes at the top of the list (23% of time spent on first
attribute) versus bottom of the list (13% of the time spent
on last attribute). This influenced the amount of time indi-
viduals fixated on attributes they felt were more important
to them (Table 2). In the conventional summary, 18% of fix-
ation duration was spent on the most important attribute,
followed by 16% of duration on the second most important
attribute. The DCIDA summary demonstrated an increase
to 30% and 18% respectively. Similarly, in the conventional
display, 12% of time was spent on the least important attri-
bute, compared to only 5% of time using the DCIDA. Ana-
lyzing the subgroup of participants that changed their
preferred option between the conventional and DCIDA
summaries shows even greater differences in fixations
(Table 2). The heatmaps in Figure 4 describe the influence
of DCIDA on two individuals.
Quantitative responses
For the 12 participants using the OSA tool, based on
the conventional display, 5 participants chose the Oral
Figure 4 Heatmaps of 2 examplar respondents (where colour represents the proportion of time spent fixating in areas within the
defined cell space).
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‘very sure’ of their decision, while 4 respondents were
‘not very sure,’ with the rest being ‘moderately’ or ‘some-
what sure.’ When presented with the DCIDA version of
the summary information, 4 of the 12 participants chan-
ged their preferred option. The results for the cancer
and osteoarthritis tools produced similar results with 2
participants changing their decision for the cancer tool,1 for the osteoarthritis tool. Overall, the decisional conflict
uncertainty subscore was 50.4 for the conventional sum-
mary, reducing to 38.3 in the DCIDA version (Table 2).
Think aloud analysis
Of the 45 comments coded for usefulness, 28 (62%) were
positive. The predominant positive themes were that the
treatment information was easy to access and the DCIDA
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treatment choice. Negative comments were from individ-
uals who felt that they knew their decision and were frus-
trated that they had to negotiate all the steps before
indicating their preference option. Four of the participants
suggested that they felt ‘nudged’ to one of the choices, in a
positive frame. When prompted for further clarity, it was
not clear whether they felt this had encroached their au-
tonomy to choose or not.
Discussion
This explorative study investigated the feasibility of
using nudges based on MCDA to improve the quality of
treatment decisions. Software was developed to enable
information from conventional PtDAs to be restructured
in how it is presented to the user through dynamic and
interactive interfaces. The software was tested for both
usability and usefulness in 20 participants. Both aspects
of user testing provided some positive results, and pro-
vide important information for future development.
There is limited research on the use of behavioural eco-
nomic approaches to improve patients’ use of PtDA. A
study by Ubel et al. found that order effects in decision
aids could be unbiased by providing the patient further in-
formation (in graphical form) [10]. This is one approach
for encouraging System 2 thinking, yet a concern with tar-
geting numerous biases through this general technique is
that providing more information can sometimes over-
whelm people, causing them to revert back to System 1
thinking [54]. The DCIDA approach has sought to enable
users to read less information, but focus on information
that will most likely influence their choice.
While there has been substantial attention to ‘nudge’
theory in health [55,56], to our knowledge this theory has
not been tested in PtDAs. Default options have become
the predominant ‘nudge’ used in health interventions to
date [57], but have typically selected a single default option
for all users. For example, organ donation programs may
‘nudge’ patients to enrol by making organ donation the
default option. It has been proposed that nudges could be
used in PtDAs for conditions where the evidence clearly
indicates that one treatment option is superior to the
others [58]. This is controversial as most PtDAs are devel-
oped for preference sensitive decisions where two or more
medically appropriate options exist, and they seek to pro-
mote rather than diminish patient autonomy. DCIDA has
been designed as a bridge between non prescriptive PtDAs
and overtly prescriptive decision analysis tools.
The objective of this study was to examine if there was a
difference in response between the two versions of PtDAs.
If no difference was observed, we would reject the hypoth-
esis that the DCIDA version had any impact. While we es-
tablish some preliminary demonstration of effectiveness,
this study alone cannot ascertain whether the impact isreal or useful and should be interpreted with caution for
three primary reasons. First, participants considered the
conventional summary before the DCIDA version, there-
fore an ordering effect might have been observed whereby
they became more informed as they spent more time
viewing the information. On average 42 seconds was spent
viewing the conventional display versus 31 seconds on the
DCIDA display. It is also difficult to disentangle the effects
of each aspect of the DCIDA version that differed from
the conventional summary, such as the values clarification
exercise, the layout, or colour hues. While it would be un-
feasible to investigate the impact of each design feature,
we have subsequently evaluated the impact of ordering ef-
fects in a larger controlled study [59]. A second limitation
relates to putting the values clarification exercise at the be-
ginning of the decision aid. We deliberately presented this
exercise up front to elicit more stable values from partici-
pants. However, recent studies have suggested that it can
be problematic to engage in importance weighting too
soon in the decision-making process [60,61]. A related
third reason is that we do not know if participants who
changed their decision actually made an improved choice.
This challenge of measuring the quality of patients choices
is a limitation in all research on PtDAs [62].
Further, we acknowledge some limitations to our use of
standard measures. With regard to the System Usability
Scale (SUS), this measure has been used frequently for us-
ability evaluations of Internet-based interfaces; it is not
used typically for evaluations of Internet-based PtDAs.
Validation of the scale was based on studies of interfaces
up to 18 years old and, thus, there are contextual and de-
sign differences between DCIDA and the average tools
used to validate the SUS. However, by triangulating the re-
sults of our SUS scores with our think aloud and eye-
tracking results, we determined that the initial prototype
has acceptable usability, though we aim to improve it in
future iterations of the prototype and to use and report a
newer iteration of the SUS developed by Bangor et al. [63].
Additionally, we chose to use the Uncertainty subscale of
the Decisional Conflict Scale and acknowledge that our
analysis would have benefitted from also using the Values
Clarity subscale [49]. Use of this additional measure would
have contributed to our understanding of how DCIDA
impacted participants’ ability to arrive at stable values.
While the usability scores and improvements in deci-
sional conflict are encouraging, they suggest there is still
opportunity to further improve the tool. At the time data
collection, the DCIDA software was in alpha stage, and
the results of this research have motivated us to move to a
different platform for the beta version. The higher usabil-
ity results may also be due to the hypothetical nature of
the task. Participants did not have the diseases and were
aware they were testing a tool. In addition, subjects were
majority college-educated who had access to and comfort
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to a more heterogeneous population with lower education
or computer proficiency. We are also cognisant that it will
be important for the software to be compatible with Inter-
net use on tablets, which will require separate testing.
Given these opportunities for future research, we plan
to further explore the influence of the DCIDA in subse-
quent studies. In these, individuals will be randomized be-
tween a conventional PtDA and a DCIDA version and
plan to determine if DCIDA’s unique design features lead
to improvements in decision quality, including concord-
ance between what matters most to individual patients
and their chosen option. We propose to consider carefully
how value concordance is measured. There are no stand-
ard criteria for studying values concordance and a recent
Cochrane review [1] shows that there is substantial het-
erogeneity among the measures that authors have used to
date. We agree with the growing number of researchers
calling for further study into the “active ingredients” of
values clarification [64] and the creation of standard mea-
sures for analyzing values congruence [62,65]. Such re-
search will assist us in identifying what proportion of
people make values congruent decisions when they use
DCIDA in comparison to conventional tools. We also plan
to ask questions about patients’ attitudes to the role of
nudges in making autonomous decisions [38]. Finally, we
believe it will be crucial to include patients of varying
health literacy, and numeracy to examine the influence of
the tool in different patient groups.Conclusion
The DCIDA has been developed to enhance conventional
PtDAs to assist patients in choosing the treatment that is
most congruent with their informed values. This paper re-
ports on the theoretical motivation for the DCIDA and
then describes an experiment in which the tool is user
tested. The results give some empirical support that the
DCIDA is understandable to users and that it can help
users focus on attributes that are of individual importance
to them – to the extent that some participants changed
their decisions. A number of valuable insights were learned
for improving the next version of the DCIDA. In conclu-
sion, we propose that the DCIDA is a promising approach
to improve conventional PtDAs. Further development is
required to improve its usability and usefulness; however
research on testing preliminary effectiveness on patient
decision-making is justified.Abbreviations
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